✦ LIBER ✦

Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: A meta-analytic review

✍ Scribed by Dr. Rafael Rosell; Isabel Moreno; José Maestre; Angel Olazabal; Joan Carles; Augustin Barnadas; Albert Abad-Esteve; Nuria Ribelles; Mercedes Canela

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 709 KB
Volume: 45
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930450213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I-II study of docetaxel-ifosfami

A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer

✍ Christos Kosmas; Nicolas B. Tsavaris; Thomas Makatsoris; Adimchi Onyenadum; Mari 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 1 views

## Abstract In an attempt to develop more effective chemotherapy regimens in advanced nonsmall cell lung cancer (NSCLC), we evaluated docetaxel‐ifosfamide‐cisplatin (DIP) based on our previous experience with paclitaxel‐ifosfamide‐cisplatin. Patients with advanced NSCLC (stages III‐IV), WHO‐PS≤2, n

Prospective trial of combined hyperfract

Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer

✍ Guomin Wang; Meifang Song; Huaiyu Xu; Yi Fang 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 600 KB

Toxicity and outcome of a phase II trial

Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer

✍ Ana M. Rojas; Basil E. Lyn; Elena M. Wilson; Frances J. Williams; Nihal Shah; Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Risk of cerebral metastases and neurolog

Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer : Clinical implications for the subsequent management of the brain

✍ Allen M. Chen; Thierry M. Jahan; David M. Jablons; Joaquin Garcia; David A. Lars 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## BACKGROUND. The incidence and pattern of brain metastases was analyzed among patients who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy or chemoradiotherapy for locally advanced nonsmall‐cell lung cancer (NSCLC). ## METHODS. Between 1990 and 2004,